NCT00482209View on ClinicalTrials.gov

Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation

NACompletedINTERVENTIONAL

Enrollment

1,220

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Induced Abortion

Interventions

DRUG

Mifepristone, misoprostol

200mg mifepristone followed by 400mcg misoprostol 36-48 hours later

DRUG

mifepristone, misoprostol

200mg mifepristone followed by 800mcg misoprostol 36-48 hours later

Trial Locations (4)

Unknown

Maternity House #2, Tbilisi

Maternity House #4, Tbilisi

Zhordania Institute of Human Reproduction, Tbilisi

Hocmon Hospital, Ho Chi Minh City

All Listed Sponsors

lead

Gynuity Health Projects

OTHER

NCT00482209 - Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days Gestation | Biotech Hunter | Biotech Hunter